Investor Ideas #Potcasts 510, #Cannabis News and #Stocks on the Move (TSX: $WEED.TO) (NASDAQ: $CGC) (TSX: $RIV.TO) (CSE: $HOLL.C) (TSX: $VFF.TO)
Delta, Kelowna, BC, December 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we will be looking at a few private and public company announcements.
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced that it has entered into an arrangement agreement with its wholly-owned subsidiary The Tweed Tree Lot Inc., Canopy Rivers Inc. (TSX: RIV) and its wholly-owned subsidiary Canopy Rivers Corporation pursuant to which Canopy Growth will acquire certain assets from CRC, as set out below, in exchange for cash, common shares in the capital of Canopy Growth and the surrender of all shares in the capital of Canopy Rivers held by Canopy Growth by way of a plan of arrangement under the Business Corporations Act (Ontario).
"Canopy Rivers was established in 2017 as a strategic investment vehicle for Canopy Growth, helping us pursue key business opportunities including development of the Vert Mirabel greenhouse which today is a very important component of our Canadian cannabis operations," said David Klein, CEO, Canopy Growth. "With our new strategy in place, it is appropriate for us to divest our interest in Canopy Rivers to increase our focus as a company."
Pursuant to the Arrangement, Canopy Growth will increase its fully-diluted conditional ownership in TerrAscend Corp. ("TerrAscend") from approximately 13% to approximately 21% through the acquisition of (i) 19,445,285 exchangeable shares in the capital of TerrAscend; (ii) 2,225,714 common share purchase warrants in the capital of TerrAscend with an exercise price of $5.95 per share; (iii) 333,723 common share purchase warrants in the capital of TerrAscend with an exercise price of $6.49 per share; and (iv) a $13.2 million loan receivable owing by TerrAscend Canada Inc. to CRC. The securities in the capital of TerrAscend are not currently convertible or exercisable, and will not be convertible or exercisable until federal laws in the United States with respect to marijuana are amended.
Subject to certain rights of first refusal, Canopy Growth will also acquire all of the common shares and Class A preferred shares in the capital of Les Serres Vert Cannabis Inc. ("Vert Mirabel") held by CRC, thereby increasing Canopy Growth's ownership of the issued and outstanding common shares in the capital of Vert Mirabel from approximately 41% to approximately 67%.
In addition, all of the obligations of Tweed NB, a Fredericton, New Brunswick based subsidiary of Canopy Growth that was recently closed, owing to CRC pursuant to a royalty agreement between the parties will be terminated. The termination of the royalty agreement will provide Canopy Growth with annual cash savings of approximately $2.9 million per year over the balance of the 24-year term of the agreement.
Canopy Growth currently owns 36,468,318 Class B multiple voting shares ("MVS") and 15,223,938 Class A subordinate voting shares ("SVS") in the capital of Canopy Rivers, which represent approximately a 27% ownership interest and 84% of the aggregate voting rights of Canopy Rivers. Pursuant to the Arrangement, all of the MVS and SVS held by Canopy Growth will be repurchased by Canopy Rivers for cancellation on a cashless basis. Canopy Growth will not have any equity, debt or other interest in Canopy Rivers following completion of the Arrangement.
As additional consideration for the assets being transferred and the termination of the royalty agreement, Canopy Growth will make a cash payment to CRC of $115 million and issue an aggregate of 3,750,000 Canopy Growth Shares.
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 80 dispensaries throughout Arizona, announced the launch of its 2nd fulfillment depot for its direct-to-consumer cannabis delivery platform, Dreamy Delivery.
The Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California, to ensure a seamless customer experience in early Q4 of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the San Francisco Bay Area of Northern California and now Sacramento, California. The Company hopes to launch Dreamy in the Central Coast of California by early Q1 of 2021 with the ultimate goal of delivering Cannabis statewide.
Carl Saling, CEO of Hollister, shared, "Very excited to have opened our 2nd direct to consumer delivery depot in record time, allowing us to serve legal adults in the Sacramento Area. This furthers our quest to be a dominate direct to consumer delivery platform in California."
Pure Sunfarms, the wholly owned subsidiary of Village Farms International (TSX: VFF) (NASDAQ: VFF) announced that their quality, B.C.-grown dried flower products are now available to Canadian patients through a supply agreement with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc., one of Canada’s leading health, beauty and convenience retailers. Medical consumers in provinces and territories across Canada will now have access to Pure Sunfarms’ cannabis products, including 14g and 28g packs of dried flower.
The first of Pure Sunfarms’ cannabis products available include five varieties of 28g packs, and assorted sizes of signature strains Afghan Kush, White Rhino, Island Honey, Pink Kush, D. Bubba, and Headband. Pre-roll, oil and vape offerings will become available to Medical Cannabis by Shoppers patients in early 2021.
Registered patients across Canada can now purchase Pure Sunfarms’ products through the Medical Cannabis by Shoppers marketplace, the largest national platform providing medical consumers with convenient, one-stop access to a broad assortment of safe, high-quality products to meet their medical cannabis needs. A dedicated team of cannabis-trained advisors and Pharmacists are available by phone or email for those patients who require guidance and support.
“This agreement is a big milestone for Pure Sunfarms as the leading producer of B.C.-grown cannabis products in Canada. This marks the first time medical patients in all provinces and territories will have access to the widest selection of our dried flower products,” said Mandesh Dosanjh, President & CEO, Pure Sunfarms. “We’re thrilled to partner with the Medical Cannabis by Shoppers team, to offer consumers more choice and access to our products as the medical space evolves and grows in Canada.”
MagicMed Industries Inc. announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the PsybraryTM and the launch of the Candidate Selection program. The PsybraryTM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent filings that protect all of the above.
MagicMed's Chief Scientific Officer, Dr. Peter Facchini, stated "Our psilocybin-derivatives portfolio, which also captures dimethyltryptamine (DMT) derivatives, now includes 12 filed patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules. While we certainly don't expect to synthesize all of these molecules during the development of new drug candidates, I am pleased to announce that, as of today's launch of the Candidate Selection program, we have already synthesized more than 100 distinct psilocybin-derivative drug candidates in our state-of-the-art research and development facilities".
MagicMed's Intellectual Property Advisor, Dr. Harm Deckers, continued, "Filing this broad portfolio of patent applications is an important moment for the Company. Now that these patent applications claiming composition, manufacture, and methods of use are on file with the U.S. Patent and Trademark Office, international patent treaties prevent worldwide the issuance of claims to other parties, should any file patent applications in the future on any of these 125 million molecules".
Mental illness is a ubiquitous human experience and an insufficiently addressed medical need. Psychedelic-associated therapies offer an alternative to ineffective treatments, yet the psychedelic-based drugs themselves require improvement to achieve reduced side effects, better efficacy, and broader patient access. The mission of MagicMed is to develop the PsybraryTM to deliver such much needed improved drug candidates to its biotechnology and pharmaceutical partners.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
800 665 0411